Aspire-Lakewood Holdings, Inc.
As of Oct 22, 2026, Aspire-Lakewood Holdings is in Stage 2, the uptrend phase, now in week 15 (since Jul 10, 2026). It closed at $8.90, 50.0% below its 52-week high and above its 200-day average, which is rising.
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 6 in Auto Parts · #1 of 102 in Consumer Discretionary
Is ASBP early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ASBP among Auto Parts37th of 57 by relative strength
All 57 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | CVGI | Stage 4 · wk 3 | 92 | −8.9% |
| 2 | GTX | Stage 3 · wk 10 | 92 | −13.7% |
| 3 | DAN | Stage 1 · wk 6 | 84 | −4.9% |
| 4 | HYLN | Stage 3 · wk 1 | 84 | −25.1% |
| 5 | MGA | Stage 3 · wk 3 | 83 | +1.6% |
| 6 | ALSN | Stage 3 · wk 2 | 79 | −4.4% |
| 7 | PLOW | Stage 4 · wk 4 | 78 | +1.3% |
| 8 | MLR | Stage 2 · wk 33 | 77 | −3.5% |
| …37 | ASBP | Stage 2 · wk 15 | 33 | +6.8% |
Aspire-Lakewood Holdings: quick answers
What stage is Aspire-Lakewood Holdings in?
As of Oct 22, 2026, Aspire-Lakewood Holdings (ASBP) is in Stage 2, the uptrend phase. It entered Stage 2 on Jul 10, 2026 and is in week 15. What the four stages mean
Is Aspire-Lakewood Holdings in an uptrend?
Yes. Aspire-Lakewood Holdings is in a Stage 2 uptrend. It trades 90.4% above its 200-day average, which is rising.
How far is Aspire-Lakewood Holdings from its 52-week high?
Aspire-Lakewood Holdings closed at $8.90 on Oct 22, 2026, 50.0% below its 52-week high of $17.80. Its 52-week low is $0.16.
How has Aspire-Lakewood Holdings performed over the past year?
As of Oct 22, 2026, Aspire-Lakewood Holdings is down 29.8% over the past year and up 62.4% so far in 2026.
Which sector and industry is Aspire-Lakewood Holdings in?
Aspire-Lakewood Holdings is in the Auto Parts industry, part of the Consumer Discretionary sector.
About this companyConsumer Discretionary· Auto Parts
Aspire-Lakewood Holdings, Inc. develops sublingual drug delivery technology and manufactures automotive and industrial control systems. The company develops a nano-technology-based sublingual drug delivery system designed to enhance the pharmacokinetic performance of active pharmaceutical ingredients, supplements, and nutraceuticals to increase bioavailability, improve speed of onset, and reduce side effects. Its lead prescription product candidate, Sublingual High Dose Aspirin, targets pain management and anti-inflammatory applications. The company also develops Alprazolam in a sublingual formulation for anxiety treatment and offers Buzz Bomb Caffeine, a sublingually administered caffeine pre-workout consumer supplement. Additionally, it develops sublingual formulations of Melatonin for sleep aid, Sublingual ED for erectile dysfunction, testosterone products, and vitamins D, E, and K. The company targets therapeutic applications including heart attack and stroke, anxiety, antiplatelet conditions, nausea, pain management, and inflammation. The company also designs and manufactures engineered control systems that integrate mechanical engineering, electronics, and computer science for body, chassis, powertrain, electrical, and interior vehicle applications. It offers HMI and actuation systems, safety systems, shift systems, pedal systems, park systems, mechanical control cables, and mechatronic systems. Aspire-Lakewood Holdings, Inc. was formerly known as Aspire Biopharma Holdings, Inc. and changed its name to Aspire-Lakewood Holdings, Inc. in September 2026. Aspire-Lakewood Holdings, Inc. was incorporated in 2021 and is based in Estero, Florida.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.